In a letter addressed to Congress, and organized by Competitive Enterprise Institute, the undersigned organizations express their strong concerns regarding the Inflation Reduction Act (IRA), particularly its provisions related to prescription drug price controls. The coalition argues that the IRA’s prescription drug price control regime is unnecessary, as it focuses Read more…
The Market Institute President Charles Sauer has a new article in Real Clear Policy looking at the problems with price setting drug prices. There are attempts by the Biden Administration to use “March In” rights to implement price controls – even at the expense of future innovation. He writes: “In Read more…
The Market Institute President Charles Sauer a new article out in The Washington Examiner highlighting the successes of deregulation during the pandemic, including the proliferation of telehealth. He writes: “Like almost everything in life, the good often comes with the bad. Taylor Swift songs come with an annoying fan base, Read more…
The Market Institute President Charles Sauer has a new article in Real Clear Health highlighting a recent executive order by the Biden Administration to use antitrust enforcement. “In a move that would warm Joseph Stalin’s dead heart, the Biden Administration released (yet) another Executive Order, this one instructing federal agencies to ramp Read more…
Market Institute President Charles Sauer has a new piece in RealClear Policy on patent rights. The White House recently issued a patent waiver for Covid-19 vaccines. Here’s an excerpt of Sauer’s article: “President Biden recently made what the Wall Street Journal referred to as the worst single Presidential decision since Nixon’s Read more…
The Market Institute Charles Sauer is out with a new piece in the Washington Examiner on the issue of surprise billing and how the Biden administration plans on implementing recently passed legislation. “Insurance companies largely won their fight in Congress last year to gain the ability to set the prices Read more…
Market Institute President Charles Sauer has a new article in the Washington Examiner on how government interference affects the development of new vaccines. Here’s an excerpt: “Vaccines are now being distributed around the world. However, the process is far from smooth, and many are getting frustrated. They should be. Israel Read more…
The Market Institute President Charles Sauer has a new piece in the Washington Examiner looking at the White House’s newest proposed regulation on importing foreign prices controls for prescription drugs. Here is an excerpt: “On July 20, 1969, the United States landed on the moon. In November, a couple of Read more…
The Market Institute’s Charles Sauer is out with a new Op-ed in the Washington Examiner looking at legislation on “Surprise Billing.” In the midst of intense negotiations on a phase 4 coronavirus relief bill, a debate is brewing over the inclusion of a ‘fix’ to the issue of surprise billing. Read more…
The Market Institute’s Charles Sauer recently took to the Washington Examiner with a piece on surprise billing legislation. In his words: “Congressmen are talking about backstabbing doctors with a legislative solution that will also undermine our whole healthcare system. Their solution is only supported by the insurance industry and congressmen Read more…